Several high frequency restriction fragment length polymorphisms (RFLPs) associated with the human gene for apolipoprotein B have been previously reported by Priestly et al. 1 The EcoRI RFLP here was shown to be very strongly associated with the Ag(t/z) Immunochemlcal polymorphism of human low density llpoprotelns, allowing correct Ag(t/z) phenotyplng of 17 (out of 17 tested) unrelated individuals. The Xbal RFLP was associated with the Ag(g/c) Immunochemlcal polymorphism, permitting correct phenotyplng of 14 (out of 17 tested) unrelated Individuals. Its close association with an RFLP permitted localization of the Ag(t/z) polymorphism to the C-termlnal end of the apolipoprotein B peptlde, and allowed detailed discussion of Its probable molecular basis. (Arteriosclerosis 7:301-305,
B ecause of the central role played by apolipoprotein B (apo B) in the transport of lipids, and especially of cholesterol in low density lipoprotein (LDL), it is possible that a genetic variation in apo B could help explain why some individuals are susceptible to atherosclerosis. Apo B has been cloned, and its entire amino acid sequence has been determined. 2 ' 3 This achievement permits the reexamination of previously identified genetic variations at the level of nucleotide sequence.
Phenotypic expression of genetic variation in LDL has been studied extensively using antisera against allelic variants of the donors' LDL developed in the sera of multiply transfused patients. Population and family studies have confirmed that these immunochemical polymorphisms are inherited in an autosomal codominant mode, implicating the amino acid sequence variation in a protein component of LDL. The data were analyzed and summarized 4 to indicate the existence of five distinct sites of immunochemical polymorphism: Ag(a1/d), Ag(x/y), Ag(t/z), Ag(g/c), and Ag(h/i). The order of the corresponding five loci along the chromosome remains unknown. (In the terminology employed, 'Ag' means 'antigen group', and 'a1/d' are the two alternate forms of an epitope present at the first-mentioned site; 'x/y' are the two alternate epitopes at the second mentioned site, etc.) Phenotypically, individuals may be homozygous or heterozygous at each of these five sites; thus, at the first site, an individual might be a1 ,a1 or d,d or a1 ,d. Therefore, 3 5 = 243 possible human Ag phenotypes exist, of which 44 have been identified. 4 A monoclonal antibody against apo B which also recognizes the Ag(g/c) epitope and binds 40 times more tightly to LDL from Ag(c,c) individuals than to LDL from Ag(g,g) individuals has been developed. The existence of this antibody identified the gene for apo B as the general locus for the Ag system; possibly all of the five Ag epitopic pairs represent one or the other of two alternative amino acids at five distinct locations on the polypeptide for this apolipoprotein. 5 In this communication, we demonstrate that two previously identified restriction fragment length polymorphisms (RFLPs) associated with the apo B structural gene 1 are also closely associated with the Ag system epitopes; one is very closely associated with Ag(t/z) and the other is less well associated with Ag(g/c).
Methods

Subjects
We tested 17 unrelated, normal individuals. They were a typical American population, highly diverse in ethnic origin, including two Orientals, one black, one of Mexican ancestry, and one each of Hungarian, Lithuanian, Latvian, and Russian ancestry. The remainder were of Western European ancestry.
Genomlc DNA Preparation
Human nuclear DNA from the 17 individuals was prepared from white blood cells in 30 ml of peripheral blood, as previously described. 6
cDNA Probes and Restriction Endonucleases
We have previously cloned several cDNA fragments of apo B. 6 ' 7 One of the cDNA fragments, A6c, which covers 3.5 kb of apo B at the 5' end, was used first in our studies.
301
Other cDNA fragments, AB6 and ABM, which together span 4.6 kb of apo B on the 3' portion, were kindly provided by James Scott, MRC, Clinical Research Centre, Harrow, United Kingdom. These cDNA clones were grown individually, and DNA inserts were isolated and radiolabelled with a-^P-dCTP by a random-priming method as described, 8 yielding probe preparations with specific activities of 0.9 to 1.3 x 10* cpm//xg.
All of the restriction endonucleases used in our studies were purchased from Bethesda Research Laboratories, Gaithersburg, Maryland.
Genomlc Southern Hybridization
Human genomic DNA from 17 individuals was digested with various restriction enzymes for at least 10 hours under the conditions suggested by the supplier but with a five-to sevenfold excess. After digestion, the DNA fragments were electrophoresed in 1 % (wt/vol) agarose gels and were transferred onto nylon filters (Biodyne Transfer Membrane). The hybridizations were performed as previously described 6 for at least 24 hours. The filters were then exposed against Kodak XAR-5 films using two intensifying screens (Dupont Cronex Quanta 11 F) at -70°C for 24 to 72 hours.
Ag Phenotyplng
Passive hemagglutination inhibition experiments were conducted by using nine different red cell types, each coated with another LDL preparation for a determination of the complete Ag system phenotypes of the 17 individuals. 4
Statistical Analysis
The calculation for the probabilities of association between the EcoRI and the Ag (t/z) epitopes was performed in the same manner as described in detail for Xbal with Ag(g/c); however, it was simpler, for there were no offdiagonal terms.
The probabilities of association between the Xbal RFLP and the Ag(g/c) epitopes were computed according to the binomial theorem, assuming allele frequencies for Ag(g) of 0.7 and Ag(c) of 0.3. Thus 49%, 42%, and 9% of individuals selected at random were expected to be Ag(g/g), Ag(g/c), or Ag(c/c), respectively. The probability that five individuals selected at random would all be Ag(g/g) was 0.49 s = 0.028. The probability that nine additional individuals selected at random would include at least eight who were Ag(g/c) was 8(0.24) 8 (0.58) + (0.42) 9 = 0.005. The probability that three additional individuals selected at random would include at least one Ag(c/c) was 1 -(0.91) 3 = 0.25. These probabilities are independent and multiply to yield the overall probability: 0.028 x 0.005 x 0.25 = 3.5 10~5. However, this number should be doubled, for if the match were due to chance, either X1 or X2 could appear associated with Ag(g). Moreover, this number should be compared with the average probability which would be computed over many trials of a truly random distribution; i.e., this is Vi for each of the three genotypes, or (Vi) 3 = 0.125. Thus, the probability, normalized to 1, that the observed distribution is due to chance is p = 2 x 3.5 x = 5.6 x 10-4 . (See Table 1 .) 
Results
The cDNA probe covering the 5' region of apo B coding sequence, A6c, was first used to detect restriction fragment length polymorphisms (RFLPs). Although three RFLPs were detected by restriction enzymes Mspl, Pvull, and Xbal, no correlation was revealed between these and any of the Ag pairs. Then cDNA probes spanning 4.6 kb of the 3' region of apo B, AB6, and ABM, were employed. Since five RFLPs, detected by Mspl, Xbal, EcoRI, EcoRV, and BamHI, have been previously reported, 1 these enzymes were used to digest the 17 DNA samples. Two of It was digested with restriction endonuclease EcoRI and hybridized to AB6/AB14. Ten individuals are homozygous for 12 ± 2-kb bands (1, 2,4,5,6, 7,10,11,14, and 15); one is homozygous for a 14-kb band (8) ; and four are heterozygotes (3, 9, 12 , and 13). The RFLP detected by restriction enzyme EcoRI are shown in Figure 1 for 15 individuals. Of 17 individuals tested, ten were homozygous for one allele, giving 12 kb and 2 kb bands upon enzyme digestion (genotype R1R1); two were homozygous for the other, less common allele producing a 14 kb band (genotype R2R2); and the remaining five were heterozygous, containing both alleles (genotype R1R2). These 17 individuals were also Ag-typed using appropriate antibodies, and the results are listed in Table 2 . In Table 2 , the + and -indicate the presence or absence of the corresponding Ag epitope or RFLP. The EcoRI restriction site polymorphism showed a perfect correspondence with the Ag(t/z) epitope for these 17 individuals.
The RFLP detected by restriction enzyme Xbal showed three individuals homozygous for the 5.0 kb band (genotype X1X1), five homozygous for the 8.5 kb band (genotype X2X2), and nine heterozygotes (genotype X1X2). Some of these are illustrated in Figure 2 . When compared with the Ag typing, an imperfect match was found with the Ag(g/c) epitope-14 out of 17 individuals were consistently Ag(g/c) phenotyped by the Xbal RFLP (Table 3 ).
Discussion
The statistical analysis in the Methods section shows the probabilities that random chance could be responsible for the observed agreement between the Ag phenotypes and the RFLP genotypes. In both cases the probability is very small. Thus, the probability that random chance is the ba-sis for the consistent assignment of 17 of 17 EcoRI RFLP with their respective Ag(t/z) phenotypes is about one in one million, while the probability that chance is the basis for the consistent assignment of 14 of 17 Xbal RFLP with their respective Ag(g/c) phenotypes is about one in 1750.
Single base pair substitutions are responsible for both the EcoRI and the Xbal RFLPs. Unpublished results quoted by Berg et al. 9 state: The EcoRI site polymorphism alters the apo B protein sequence by substituting lys (AAA) for glu (GAA) at residue 4154 in the mature protein" and ". . . loss of the Xbal site is caused by a silent C to T mutation in the third base of the threonine codon at residue 2488 in the mature protein. . . ."
Since the alternate lys or glu residues encoded at the EcoRI site bore positive or negative charges, we may assume that they were exposed to solvent at the surface of the LDL and, thus, they would be candidates for actually being the structural alteration recognized by the Ag(t/z) antibodies, although this remains to be proven. In any case, the RFLP closely associated with the Ag(t/z) epitope is located toward the C-terminal end of apo B.
The Xbal mutation Is silent, that is, it does not result in an amino acid alteration. Therefore, it cannot coincide with the Ag(g/c) locus, a result already anticipated from the imperfect association of only 14 out of 17 tested individuals. The Xbal mutation is located at residue 2488, while the Ag(g/c) mutation is located on the N-terminal thrombolytic peptide T-4 of apo B (S. G. Young, personal communication), which comprises residues 1 to 1297 on the mature protein. 2 Thus, the two sites would appear to be separated by at least 1191 residues, comprising about one-quarter of the length of apo B. A recent report 9 shows a significant correlation between the Xbal polymorphism and another Ag locus, Ag(x). From the data presented in that report, it appears that not having the Ag(x) antigen, that is, being Ag(x -) -or, presumably, being Ag(y/y) since x and y are antithetical alleles -is associated with possessing two Xbal X1 alleles. This is of particular interest because of a likely association of Ag(x-) with increased serum triglyceride and cholesterol levels. 10 Moreover, an association between the Xbal polymorphism and altered plasma cholesterol and triglyceride levels has been found in an independent study: "Subjects homozygous and heterozygous for the presence of an Xbal restriction site had mean serum triglyceride levels 36% higher (p = 0.02) than those in homozygotes without the restriction site; there was a less substantial difference (p = 0.03) in serum cholesterol." 11 In this regard, a similar calculation was performed. The p value for the association between Ag(x/y) and the Xbal RFLP lies at about the 10% level of significance (p = 0.10); a larger sample size clearly is required. No other associations between the RFLP and other Ag pairs are apparent in these data. *Not tested but assumed positive because of the extreme rarity of the homozygote for Ag(h) allele. tFor the Ag loci, the frequencies listed are those determined from a Swiss population of 362 Individuals. For the RFLP the frequencies are those determined from the 17 individuals in this study. The Ag frequencies of the 17 individuals shown above are: a1/d, 0.50/0.50; g/c, 0.65/0.35; h/i, 0.06/0.94; x/y, 0.21/0.79; fz, 0.74/0.26. Given the small sample size, these are not significantly different from those reported for the Swiss population.
Given the association that we report here between Xbal and Ag(g/c) and the association reported by Law et al. 11 between Xbal and triglyceride and cholesterol levels, we would also expect to find an association between Ag(g/c) and triglyceride and cholesterol levels. However, in at least one recent study that compared normal controls, patients with hypercholesterolemia, and patients with coronary heart disease, no relationship was found between cholesterol levels and coronary heart disease and Ag(g/c). 12 Thus, a puzzle remains: Are Ag(g/c) or Ag(x/y) or both associated with Xbal, and what are the relationships with serum triglyceride and cholesterol? Is it possible that some of these apparent inconsistencies are due to differences between the populations examined? These questions are being investigated by additional studies currently in progress.
